Metformin for Older Patients With Heart Failure With Preserved Ejection Fraction | MicrobiomeTrials← Back to trialsNCT05093959
Metformin for Older Patients With Heart Failure With Preserved Ejection Fraction
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2022-01-04Est. Completion: 2025-12-18
Enrollment target: 86 participants Locations- Atrium Health Sanger Heart and Vascular Clinic Institute, Charlotte, North Carolina, United States
- Wake Forest School of Medicine, Winston-Salem, North Carolina, United States
Other microbiome trials you might be interested in
Mitral Valve ProlapseMitral Regurgitation
Mitral regurgitation (MR) is the second most frequent valvular heart disease and the second most frequent indication for…
Milan, ItalyEst. completion Jun 1, 2029
Heart Failure With Preserved Ejection Fraction
The goal of this research study is to understand whether an at-home exercise program started after hospitalization for H…
Burlington, United StatesCompleted Sep 30, 2023